Amotivational syndrome.
D000928:Antidepressive Agents / Q000627:therapeutic use; D002170:Canada; D003156:Community Mental Health Services; D003863:Depression / Q000139:chemically induced* / Q000188:drug therapy; D005476:Fluphenazine / Q000009:adverse effects; D006801:Humans; D008722:Methods; D009042:Motivation; D010348:Patient Care Team; D010640:Phenothiazines / Q000009:adverse effects*; D011613:Psychotherapy; D012559:Schizophrenia / Q000188:drug therapy*
D000928:Antidepressive Agents; D010640:Phenothiazines; D005476:Fluphenazine